{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:03:58Z","timestamp":1784354638262,"version":"3.55.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>In contrast to hereditary angioedema (HAE) due to C1-inhibitor deficiency, the detection of pathogenic variants in genes linked to HAE with normal C1 inhibitor levels (HAE-nC1INH) is required for the diagnosis of the corresponding types of the disease. The mainstreaming of genomic technology and the increasing use of next generation sequencing have increased the possibility of an unintentional detection of HAE-nC1INH pathogenic variants and allowed the incidental finding of variants of uncertain significance (VUS) in the relevant genes. Apart from <jats:italic>F12<\/jats:italic> and <jats:italic>PLG<\/jats:italic> pathogenic variants, the current level of evidence on the prevalence and penetrance of variants associated with HAE-nC1INH does not support the reporting of their incidental finding. On the other hand, although VUS should not be used in clinical decision-making, further consideration is warranted (a) for VUS found in exon 9 of the <jats:italic>F12<\/jats:italic> gene after a diagnostic genetic analysis of individuals either with or without personal or family history of angioedema, and (b) for VUS found in any of the other genes linked to HAE-nC1INH, after genetic analysis performed in the context of differential diagnosis of angioedema cases. Given the complexity of interpreting, reporting and communicating incidental findings, a close partnership between patients, clinicians, laboratory geneticists and genetic counsellors is essential to optimize the management of these results.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1605727","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:10:26Z","timestamp":1750133426000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Incidental findings related to genes associated to HAE-nC1INH: how to proceed?"],"prefix":"10.3389","volume":"16","author":[{"given":"Anastasios E.","family":"Germenis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Sanoudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.10.004","article-title":"International consensus on the use of genetics in the management of hereditary angioedema","volume":"8","author":"Germenis","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s12016-025-09027-4","article-title":"Hereditary angioedema with normal C1 inhibitor: An updated international consensus paper on diagnosis, pathophysiology and treatment","volume":"68","author":"Zuraw","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12920-019-0561-0","article-title":"Criteria for reporting incidental findings in clinical exome sequencing - a focus group study on professional practices and perspectives in Belgian genetic centers","volume":"12","author":"Saelaert","year":"2019","journal-title":"BMC Med Genomics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ajhg.2012.05.021","article-title":"Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes","volume":"91","author":"Johnston","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100866","article-title":"ACMG SF v3.2 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Miller","year":"2023","journal-title":"Genet Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ajhg.2020.05.002","article-title":"Management of secondary genomic findings","volume":"107","author":"Katz","year":"2020","journal-title":"Am J Hum Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/jamaoncol.2017.4573","article-title":"Ascertainment bias and estimating penetrance","volume":"4","author":"Sorscher","year":"2018","journal-title":"JAMA Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101142","article-title":"Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"26","author":"Gordon","year":"2024","journal-title":"Genet Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2024.100223","article-title":"Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency","volume":"3","author":"Vincent","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"key":"B11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jaci.2024.05.017","article-title":"DAB2IP associates with hereditary angioedema: insights into the role of VEGF signaling in HAE pathophysiology","volume":"154","author":"D\u2019Apolito","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.10.016","article-title":"Differentiating histaminergic and nonhistaminergic angioedema with or without urticaria","volume":"150","author":"Farkas","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2017.04.004","article-title":"Hereditary angioedema with normal C1 inhibitor: Update on evaluation and treatment","volume":"37","author":"Magerl","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaip.2017.09.025","article-title":"Hereditary angioedema with normal C1 inhibitor and F12 mutations in 42 Brazilian families","volume":"6","author":"Veronez","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B15","unstructured":"ACGS best practice guidelines for variant classification in rare disease 2020\n          \n          \n            \n              Ellard\n              S\n            \n            \n              Baple\n              EL\n            \n            \n              Callaway\n              A\n            \n            \n              Berry\n              I\n            \n            \n              Forrester\n              N\n            \n            \n              Turnbull\n              C\n            \n          \n          \n          2020"},{"key":"B16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2023.11.005","article-title":"Will variants of uncertain significance still exist in 2030","volume":"111","author":"Fowler","year":"2024","journal-title":"Am J Hum Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24309","article-title":"Variant interpretation using population databases: Lessons from gnomAD","volume":"43","author":"Gudmundsson","year":"2022","journal-title":"Hum Mutat"},{"key":"B18","unstructured":"Clinical Genome Resource: ClinVar and ClinGen partnership"},{"key":"B19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.7326\/M21-4109","article-title":"The challenge of genetic variants of uncertain clinical significance: A narrative review","volume":"175","author":"Burke","year":"2022","journal-title":"Ann Intern Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxab070","article-title":"Understanding genetic variants of uncertain significance","volume":"27","author":"Joynt","year":"2021","journal-title":"Pediatr Child Health"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1136\/jmg-2023-109488","article-title":"Variant reclassification and clinical implications","volume":"61","author":"Walsh","year":"2024","journal-title":"J Med Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/jgc4.1558","article-title":"The long-term impact of receiving incidental findings on parents undergoing genome-wide sequencing","volume":"31","author":"Cheung","year":"2022","journal-title":"J Genet Couns"},{"key":"B23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41436-020-00957-2","article-title":"Clinical and psychological outcomes of receiving a variant of uncertain significance from multigene panel testing or genomic sequencing: a systematic review and meta-analysis","volume":"23","author":"Mighton","year":"2021","journal-title":"Genet Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1605727\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T04:10:27Z","timestamp":1750133427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1605727\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2025.1605727"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1605727","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"article-number":"1605727"}}